Breast cancer (BC) is characterized by the abnormal proliferation of cells within the lining of the breast lobules or ducts. It stands as the most prevalent malignancy affecting women worldwide. In 2020, it overtook lung cancer to become the primary cause of global cancer incidence, with approximately 2.3 million new cases, constituting 11.7% of all cancer cases. Statistics of breast cancer in India indicate substantial increase in incidence, rising by almost 50% between 1965 and 1985. The estimated number of incident cases in India was 118,000 in 2016. According to Globocan data for 2020, BC in India contributed to 13.5% (178,361) of all cancer cases and accounted for 10.6% (90,408) of all cancer-related deaths.
Breast cancer treatment is a collaborative effort involving various disciplines. The majority of women diagnosed with early-stage BCs are eligible for either breast-conserving surgery with radiotherapy or mastectomy. The survival rates exhibit significant variability but show an optimistic trajectory, largely attributed to transformative changes in screening methods, early diagnosis, and advancements in treatment modalities.
The evolution of breast cancer classification and staging encompasses different strategies, with intrinsic (molecular) subtyping proving crucial in clinical trials and fostering a deeper understanding of the disease. Ongoing research is actively exploring novel technologies for the detection of distant metastases, recurrent disease, and the assessment of response to such cancer management. Let’s know more in the following article.